ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AVCT Avacta Group Plc

47.75
-1.25 (-2.55%)
Last Updated: 09:51:38
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Avacta Group Plc LSE:AVCT London Ordinary Share GB00BYYW9G87 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.25 -2.55% 47.75 47.50 48.00 48.75 47.50 48.75 1,273,203 09:51:38
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 10.06M -39.19M -0.1382 -3.46 135.43M

Avacta Group PLC Presenting at London Growth and Innovation Forum

11/01/2017 7:00am

RNS Non-Regulatory


TIDMAVCT

Avacta Group PLC

11 January 2017

11(th) January 2017

Avacta Group plc

("Avacta" or "the Group" or "the Company")

Avacta to present at the London Growth and Innovation Forum

Avacta Group plc (AIM: AVCT), the developer of Affimer(R) biotherapeutics and research reagents, is pleased to announce that its Chief Executive, Alastair Smith, will be presenting at the London Growth and Innovation Forum on 31(st) January 2017 at the Business Design Centre, London.

The Growth & Innovation Forum is a one-day investor exhibition showcasing innovative technology led companies.

Avacta Group's management team will be at stand 18 during the day and Chief Executive Alastair Smith will be presenting at 1500 in the Babbage room.

For more information, including registration details, please visit:

http://www.sharesmagazine.co.uk/events/event/GIF2017

ENDS

Notes to Editors

For further information from Avacta Group plc, please contact:

 
 Avacta Group plc                          Tel: +44 (0) 844 414 0452 
  Alastair Smith, Chief Executive           www.avacta.com 
  Officer 
  Tony Gardiner, Chief Financial 
  Officer 
 finnCap Ltd                               Tel: +44 (0) 207 220 0500 
  Geoff Nash / Giles Rolls                  www.finncap.com 
  - Nominated Adviser 
  Tim Redfern / Alice Lane 
  - Corporate Broking                       Tel: +44 (0) 203 705 9318 
                                            Tel: +44 (0) 203 705 9217 
  WG Partners                               www.wgpartners.co.uk 
  David Wilson 
  Nigel Barnes 
  Claes Spang 
 Zyme Communications (Trade                Tel: +44 (0)7787 502 947 
  and Regional Media)                       katie.odgaard@zymecommunications.com 
  Katie Odgaard 
                                            Tel: +44 (0) 203 727 1000 
  FTI Consulting (Financial                 avacta@fticonsulting.com 
  Media and IR) 
  Simon Conway / Natalie Garland-Collins 
 

About Avacta Group plc (www.avacta.com)

Avacta's principal focus is on its proprietary Affimer(R) technology which is a novel engineered alternative to antibodies that has wide application in Life Sciences for diagnostics, therapeutics and general research and development.

Antibodies dominate markets worth in excess of $50bn despite their shortcomings. Affimer technology has been designed to address many of these negative performance issues, principally; the time taken to generate new antibodies, the reliance on an animal's immune response, poor specificity in many cases, and batch to batch variability. Affimer technology is based on a small protein that can be quickly generated to bind with high specificity and affinity to a wide range of protein targets.

Avacta has a pre-clinical biotech development programme with an in-house focus on immuno-oncology and bleeding disorders as well as partnered development programmes. Avacta is also commercialising non-therapeutic Affimer reagents through licensing to developers of life sciences research tools and diagnostics.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRALFFSLLFIILID

(END) Dow Jones Newswires

January 11, 2017 02:00 ET (07:00 GMT)

1 Year Avacta Chart

1 Year Avacta Chart

1 Month Avacta Chart

1 Month Avacta Chart

Your Recent History

Delayed Upgrade Clock